insights_auto
Why is ARGX down 14,66%?
Dive Deeperchevron_right
ARGX:NASDAQ
argenx SE - ADR
792,33 USD
arrow_downward
-14,66%(-136,11) 1D
8-окт., 11:27:38 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARGX...
Open
831,23 USD
High
832,24 USD
Low
788,88 USD
Mkt. cap
50,16 млд
Avg. vol.
263,56 миң
Volume
1,14 млн
P/E ratio
30,10
52-wk high
1 072,75 USD
52-wk low
661,85 USD
EPS
26,32 USD
Beta
0,45
Shares outstanding
62,89 млн
No. of employees
2 миң
Open
831,23 USD
High
832,24 USD
Low
788,88 USD
Mkt. cap
50,16 млд
Avg. vol.
263,56 миң
Volume
1,14 млн
P/E ratio
30,10
52-wk high
1 072,75 USD
52-wk low
661,85 USD
EPS
26,32 USD
Beta
0,45
Shares outstanding
62,89 млн
No. of employees
2 миң
News stories
From web sources and news partners
Investing.com
·
47 мүнөт мурун
Stifel reiterates argenx stock Buy rating after trial stopped
AD HOC NEWS
·
1 саат мурун
Argenx stock falls to EUR 726.20 with USD 50.2 billion market cap
Investor's Business Daily
·
1 саат мурун
Former Highflying Biotech Hits The Skids On A Surprise Failure
GuruFocus
·
3 саат мурун
argenx (ARGX) Shares Drop 14.2% Pre-Market Amid Market Uncertain
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About argenx SE - ADR